Vivoryon Therapeutics N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
13 mei 2015 - 08:11
Statutaire naam
Vivoryon Therapeutics N.V.
Titel
Probiodrug reports First Quarter 2015 Business Update
Bericht
HALLE/SAALE, Germany, 13 May 2015 - Probiodrug AG (Euronext Amsterdam: PBD), a biopharmaceutical company developing novel therapeutic solutions to treat Alzheimer's disease (AD), today announces its first quarter business update for the period ended 31 March 2015, in the form of an interim management report.
The interim management report including the first quarter 2015 business update is available for download on the company website (http://www.probiodrug.de/investors/reports-and-presentations/).
Datum laatste update: 29 juli 2024